Cardiol Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	145	151	72	44	142	91
Market Cap Growth	1.19%	110.34%	63.29%	-69.05%	55.49%	-22.93%
Enterprise Value	134	135	31	-21	113	75
Last Close Price	1.31	1.85	1.10	0.69	2.33	2.78
PS Ratio	-	-	-	-	1803.25	-
PB Ratio	15.20	6.11	2.54	0.84	1.86	6.88
P/TBV Ratio	15.20	6.11	2.56	0.85	1.87	7.13
EV/Sales Ratio	-	-	-	-	1441.08	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.00	0.01
Asset Turnover	-	-	-	-	0.00	-
Quick Ratio	3.59	4.41	4.25	6.12	7.29	5.66
Current Ratio	3.89	4.52	4.36	6.27	7.54	5.94
Return on Equity (ROE)	-347.98%	-138.47%	-69.93%	-48.16%	-70.69%	-147.74%
Return on Assets (ROA)	-148.83%	-73.43%	-37.71%	-34.47%	-46.58%	-82.38%
Return on Capital Employed (ROCE)	-375.60%	-162.10%	-104.90%	-79.20%	-50.70%	-154.70%
Earnings Yield	-23.94%	-24.30%	-39.19%	-70.37%	-22.28%	-22.60%
FCF Yield	-16.69%	-16.61%	-35.17%	-62.10%	-16.58%	-10.04%
Buyback Yield / Dilution	-21.91%	-11.02%	-3.13%	-44.61%	-44.77%	-15.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.